Cartesian Therapeutics
RNAC
RNAC
80 hedge funds and large institutions have $38M invested in Cartesian Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $57.2M → $38M (-$19.2M)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
80
Holding in Top 10
–
Calls
$8K
Puts
$1K
Top Buyers
| 1 | +$3.56M | |
| 2 | +$415K | |
| 3 | +$274K | |
| 4 |
Millennium Management
New York
|
+$149K |
| 5 |
State Street
Boston,
Massachusetts
|
+$116K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$560K | |
| 3 | -$481K | |
| 4 |
Bank of New York Mellon
New York
|
-$177K |
| 5 |
BlackRock
New York
|
-$157K |